J Korean Ophthalmol Soc > Volume 52(3); 2011 > Article
Journal of the Korean Ophthalmological Society 2011;52(3):285-292.
DOI: https://doi.org/10.3341/jkos.2011.52.3.285    Published online March 15, 2011.
Effect of 23-gauge Sutureless Vitrectomy & Preoperative Bevacizumab on Results of Diabetic Vitrectomy.
Dae Heon Han, Hee Jin Sohn, Dae Young Lee, Dong Heun Nam
1Department of Ophthalmology, Gachon University Gil Hospital, Incheon, Korea. eyedawns@gilhospital.com
2Department of Ophthalmology, Hongik Hospital, Seoul, Korea.
23게이지 유리체절제술 및 술 전 베바시주맙 주입술 여부에 따른 당뇨 유리체절제술의 결과
한대헌1⋅손희진2⋅이대영1⋅남동흔1
Department of Ophthalmology, Gachon University Gil Hospital1, Incheon, Korea Department of Ophthalmology, Hongik Hospital2, Seoul, Korea
Abstract
PURPOSE
To investigate the results of 23-gauge sutureless vitrectomy and preoperative bevacizumab in diabetic retinopathy cases. METHODS: A total of 212 eyes received pars plana vitrectomy by a single surgeon for proliferative diabetic retinopathy and were followed up for at least 6 months. The change of visual acuity and operative complications among the 20-gauge vitrectomy (group I, 86 eyes), 23-gauge vitrectomy (group II, 30 eyes), and 23-gauge vitrectomy with preoperative intravitreal bevacizumab (IVB) injection (group III, 96 eyes) were retrospectively analyzed. RESULTS: One month postoperatively, visual improvement was better in groups II and III than in group I. Three months postoperatively, visual improvement was better in group III than in groups I and II. Six months postoperatively, visual improvement in group III was better than in group I, but there was no significant difference between group II and III. Intraoperative retinal breaks and postoperative vitreous hemorrhage were less common in group III than in groups I and II. CONCLUSIONS: In patients with proliferative diabetic retinopathy, 23-gauge sutureless vitrectomy showed faster visual recovery compared with 20-gauge vitrectomy, and vitrectomy with preoperative bevacizumab had less intraoperative and postoperative complications than vitrectomy without preoperative bevacizumab.
Key Words: 20-gauge vitrectomy;23-gauge vitrectomy;Intravitreal bevacizumab injection


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next